Seyed Davar Siadat, Farzam Vaziri, Mamak Eftekhary, Maryam Karbasian, Arfa Moshiri, Mohammad R. Aghasadeghi, Mehdi S. Ardestani, Meghdad Abdollahpour Alitappeh, Amin Arsang, Abolfazl Fateh, Shahin Najar Peerayeh, Ahmad R. Bahrmand
Osong Public Health Res Perspect 2015;6(1):9-13. Published online February 28, 2015
Objectives
Development of an efficacious vaccine against brucellosis has been a challenge for scientists for many years. At present, there is no licensed vaccine against human brucellosis. To overcome this problem, currently, antigenic determinants of <i>Brucella</i> cell wall such as Lipopolysaccharide (LPS) are considered as potential candidates to develop subunit vaccines. Methods
In this study, <i>Brucella abortus</i> LPS was used for conjugation to <i>Neisseria meningitidis</i> serogroup B outer membrane vesicle (OMV) as carrier protein using carbodiimide and adipic acid–mediated coupling and linking, respectively. Groups of eight BALB/c mice were injected subcutaneously with 10 μg LPS alone, combined LPS + OMV and conjugated LPS–OMV on 0 days, 14 days, 28 days and 42 days. Anti-LPS IgG was measured in serum. Results
The yield of LPS to OMV in LPS–OMV conjugate was 46.55%, on the basis of carbohydrate content. The ratio for LPS to OMV was 4.07. The LPS–OMV conjugate was the most immunogenic compound that stimulated following the first injection with increased IgG titer of ∼5-fold and ∼1.3-fold higher than that produced against LPS and LPS in noncovalent complex to OMV (LPS + OMV), respectively. The highest anti-LPS IgG titer was detected 2 weeks after the third injection (Day 42) of LPS–OMV conjugate. The conjugated compound elicited higher titers of IgG than LPS + OMV, that showed a 100–120-fold rise of anti-LPS IgG in mice. Conclusion
These results indicate that our conjugated LPS–OMV can be used as a brucellosis vaccine, but further investigation is required.
Citations
Citations to this article as recorded by
Engineering Bacterial Extracellular Vesicles as Nanoweapons to Fight against Bacterial Infections Yejiao Shi, Yuting Li, Zhinan Liu, Xiangxiang Kong, Xiaochun Hu, Xi Liu, Cuiping Zhang, Honggang Hu Research.2026;[Epub] CrossRef
Engineered bacterial extracellular vesicles for gastrointestinal diseases Xinke Nie, Qiqiong Li, Ying He, Yushan Xu, Shanfeng Qiao, Xingdong Wang, Fan Meng, Junhua Xie, Shaoping Nie Journal of Controlled Release.2025; 385: 113972. CrossRef
Immunopotential of the Combine Vaccine against Fowl Cholera and Avian Influenza Virus in Poultry M. Rafique, A. Shahzad, G. Z. Jahangir, S. Naz Molecular Genetics, Microbiology and Virology.2025; 40(1): 83. CrossRef
Engineered Bacterial Extracellular Vesicles: Developments, Challenges, and Opportunities Qiqiong Li, Xinyang Chen, Junhua Xie, Shaoping Nie Engineering.2025; 54: 291. CrossRef
Bioengineering Outer-Membrane Vesicles for Vaccine Development: Strategies, Advances, and Perspectives Ayesha Zahid, Hazrat Ismail, Jennifer C. Wilson, I. Darren Grice Vaccines.2025; 13(7): 767. CrossRef
Development of a colloidal gold immunochromatographic test strip for detecting the smooth Brucella Qi Wu, Xiaohan Guo, Qianhan Huang, Yujia Xie, Liping Guo, Xiangdong Yang, Mingjun Sun, Dehui Yin Scientific Reports.2024;[Epub] CrossRef
Engineered bacterial membrane vesicles are promising carriers for vaccine design and tumor immunotherapy Qiong Long, Peng Zheng, Xiao Zheng, Weiran Li, Liangqun Hua, Zhongqian Yang, Weiwei Huang, Yanbing Ma Advanced Drug Delivery Reviews.2022; 186: 114321. CrossRef
Isolation of Extracellular Vesicles of Akkermansia muciniphila as a Potential Therapeutic Platform Pegah Noori, Fattah Sotoodehnejadnematalali, Pooneh Rahimi, Seyed davar Siadat Vaccine Research.2022; 9(2): 27. CrossRef
Novel Simple Conjugation Chemistries for Decoration of GMMA with Heterologous Antigens Roberta Di Benedetto, Renzo Alfini, Martina Carducci, Maria Aruta, Luisa Lanzilao, Alessandra Acquaviva, Elena Palmieri, Carlo Giannelli, Francesca Necchi, Allan Saul, Francesca Micoli International Journal of Molecular Sciences.2021; 22(19): 10180. CrossRef
Outer membrane vesicle vaccines Francesca Micoli, Calman A. MacLennan Seminars in Immunology.2020; 50: 101433. CrossRef
Designing an immunosensor for detection of
Brucella abortus
based on coloured silica nanoparticles
Arash Shams, Bahareh Rahimian Zarif, Mojtaba Salouti, Reza Shapouri, Sako Mirzaii Artificial Cells, Nanomedicine, and Biotechnology.2019; 47(1): 2562. CrossRef
Bioengineering bacterial outer membrane vesicles as vaccine platform Matthias J.H. Gerritzen, Dirk E. Martens, René H. Wijffels, Leo van der Pol, Michiel Stork Biotechnology Advances.2017; 35(5): 565. CrossRef
First
Prev
